Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted
On February 7, the Bureau of industry and security (BIS) of the U.S. Department of Commerce released an updated "unverified list (UVL)", which was posted online on February 8. A total of 33 Chinese units have been added to the "unverified list" (UVL), including Yaoming biology and Yaoming Biology (Shanghai).
Affected by the news, Yaoming stocks plummeted across the board today. The decline of Hong Kong stock Yaoming Kant expanded by about 27% to HK $82.65. As of the morning closing, the stock fell 15.1% to HK $96.45. A-share Yaoming Kant was hit to the limit at the opening. As of the morning closing, it was reported at RMB 94.05 per share, while Yaoming biology fell more than 29%.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
AstraZeneca in China: Opportunities and Challenges [1/2]
AstraZeneca is a British pharmaceutical company founded in 1999 that focuses on discovering, developing, and commercializing prescription medicines in oncology, rare diseases, and biological medicals for cardiovascular, renal, metabolism, respiratory and immunology diseases.
Jul 05, 2022 03:21 PM
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Healthcare
AI-driven Pharmaceutical Company Phil Rivers Nets Hundreds of Mns of CNY in Series A Round
Phil Rivers, incubated by the Institute of Computing Technology of the Chinese Academy of Sciences, is a platform company that drives drug discovery with 'computational medicine'.
Yesterday 10:08 PM
Briefing Feb 07, 2022 08:09 AM
· Healthcare
The battery plant jointly built by SK innovation and Ford was started in December last year
Healthcare
Precision Autoimmune Therapeutics Earned CNY 140 Mn in Angel Financing Round
Biotech firm Precision Autoimmune Therapeutics, specializing in the research and development of innovative drugs for autoimmune diseases, will focus on the precise therapies of autoimmune diseases.
Jul 06, 2022 09:53 PM
Healthcare
Anti-cancer Drugs Developer Affinity Completed Series A+ Round
Affinity, a biopharmaceutical company focusing on developing anti-cancer drugs, gained capital favor for its tumor microenvironment activated platform and opportunities it may bring to oncology treatment.
Jul 06, 2022 08:42 PM
See more
Read next
Insight
Technology
30 Chinese Low-Carbon Tech Companies You May Want to Get to Know「2/2」
Jul 06, 2022 02:24 PM
Insight
Technology
30 Chinese Low-Carbon Tech Companies You May Want to Get to Know「1/2」
Jul 06, 2022 12:06 PM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.